DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Eric Linsley to speak at CED’s Biotech Forum: “How Early is Too Early?” in RTP, NC
News | 04. 28. 2008
